TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Nonfarm Payrolls (September)
DMRA

Damora Therapeutics, Inc.

Healthcare · Biotechnology

21.30$ +3.0% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet DMRA
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
99.6% 99.1% 98.7% 90.1% 87.3% 96.2% 98.3% 100.0%
88.3% 20.0% 95.3% 51.2% 44.8% 56.2% 82.7% 98.9%
88.3% 20.0% 95.3% 82.0% 82.3% 86.7% 82.7% 98.9%
2.8% 72.7% 1.3% 1.9% 1.9% 4.5% 5.1% 0.3%
12.7% 14.4% 3.6% 4.1% 15.6% 15.4% 15.5% 7.7%
12.7% 14.0% 3.2% 3.7% 15.2% 15.3% 7.0% 7.7%
– 0.2% 0.2% 0.3% 0.7% 0.5% 0.1% 0.0%
4.0% 5.9% 1.7% 1.3% 4.6% 4.5% 2.2% 0.2%
87.3% 85.6% 96.4% 95.9% 84.4% 84.6% 84.5% 92.3%
-94.1% -122.8% -60.8% -127.7% -297.5% -669.9% -1,619.9% -187.1%
2.9% 1.8% 0.6% 0.8% 1.4% 2.8% 6.8% 0.5%

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?